Cinoxacin
Generic Name: cinoxacin
Manufactured by TEVA. Dosage form: CAPSULE. Route: ORAL. Active ingredients: CINOXACIN (500MG). Application: ANDA073006.
Overview
Manufactured by TEVA. Dosage form: CAPSULE. Route: ORAL. Active ingredients: CINOXACIN (500MG). Application: ANDA073006.
Dosage
Available as capsule for oral use.
Related Medications
Ustekinumab-ttwe
ustekinumab-ttwe
Interleukin-12 Antagonist [EPC]
11 DESCRIPTION Ustekinumab-ttwe, a human IgG1κ monoclonal antibody, is a human interleukin-12 and -23 antagonist. Using DNA recombinant technology, ustekinumab-ttwe is produced in a Chinese hamster ovary cell line. The manufacturing process contains steps for the clearance of viruses. Ustekinumab-ttwe is comprised of 1326 amino acids and has an estimated molecular mass that ranges from 148,079 to 149,690 Daltons.
Salix Alba, Ascorbicum Acidum, Vitamin A, Vitamin E, Acetylsalicylicum Acidum
salix alba, ascorbicum acidum, vitamin a, vitamin e, acetylsalicylicum acidum
Vitamin C [EPC]
PURPOSE: Aids in temporary relief of minor aches and pains of muscles and joints† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Urinary Pain Relief
urinary pain relief
Purpose Urinary analgesic
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.